PEOPLE - Arbios Systems makes appointment:
This article was originally published in Clinica
Executive Summary
Arbios Systems (Los Angeles, California), a device company that develops proprietary liver assist technologies, has appointed Amy Factor as its interim CEO and a member of its board of directors, effective immediately. Ms Factor has been consultant to the company since November 2003 and continues to be president of AFO Advisors and AFO Capital Advisors, where she specialises in business development and strategic planning, acting as consultant to the biotechnology industry.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.